SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600620-23-000044
Filing Date
2023-11-02
Accepted
2023-11-02 06:05:32
Documents
80
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q auph-20230930.htm   iXBRL 10-Q 1048097
2 EX-31.1 auph-2023q3exx311.htm EX-31.1 10871
3 EX-31.2 auph-2023q3exx312.htm EX-31.2 11013
4 EX-32.1 auph-2023q3exx321.htm EX-32.1 5343
5 EX-32.2 auph-2023q3exx322.htm EX-32.2 5351
  Complete submission text file 0001600620-23-000044.txt   6164022

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20230930.xsd EX-101.SCH 42382
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20230930_cal.xml EX-101.CAL 71379
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20230930_def.xml EX-101.DEF 163100
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20230930_lab.xml EX-101.LAB 617460
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20230930_pre.xml EX-101.PRE 385319
74 EXTRACTED XBRL INSTANCE DOCUMENT auph-20230930_htm.xml XML 877266
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36421 | Film No.: 231369835
SIC: 2834 Pharmaceutical Preparations